Le Lézard
Classified in: Covid-19 virus
Subjects: ASI, REL, CFG

Statement by Minister Chagger on Diwali


Today, members of Hindu, Jain, and Buddhist communities in Canada and around the world celebrate Diwali

OTTAWA, ON, Nov. 14, 2020 /CNW/ - Today, members of Hindu, Jain, and Buddhist communities in Canada will celebrate Diwali?also known as the Festival of Lights.

This celebration marks a time of jubilation, reflection, compassion, and love for the world around us. It represents the triumph of light over darkness, good over evil, knowledge over ignorance, and hope over despair. It is a time when families and loved ones gather to light diyas, pray, share a meal, and exchange gifts. Homes are often decorated with lights and multi-coloured candles for the occasion.

This year, the COVID-19 pandemic has disrupted our lives in many ways and forced us to celebrate differently, which means many traditions and activities will take place virtually. Despite these difficult times, we hope the celebrations will be as special as ever and leave you all with beautiful memories.

I invite all Canadians across the country to participate in Diwali festivities and learn more about the culturally vibrant and diverse Hindu, Jain, and Buddhist communities as well as their outstanding contributions in building an even stronger and consciously more inclusive Canada for everyone.

As Minister of Diversity and Inclusion and Youth, I wish everyone celebrating Diwali a happy and meaningful festival. Keep well and stay safe.

SOURCE Canadian Heritage


These press releases may also interest you

at 08:05
Gilead Sciences, Inc. and Arcus Biosciences, Inc. today announced new data from Cohort B of ARC-9, a Phase 1b/2 study evaluating the safety and efficacy of etrumadenant, a dual A2a/b adenosine receptor antagonist, plus anti-PD-1 monoclonal antibody...

at 08:05
Detailed positive results from the DESTINY-Breast06 phase 3 trial showed that ENHERTU® (trastuzumab deruxtecan) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to standard of...

at 08:05
Detailed positive results from the DESTINY-Breast06 Phase III trial showed that ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to...

1 jun 2024
Long-Term Follow-Up Data Signal Promising Progression-Free Survival (PFS) for Selinexor in the Maintenance Setting with Median PFS of 28.4 Months in the TP53 Wild-Type and 39.5 Months in the Proficient Mismatched Repair Status (pMMR) TP53 Wild-Type...

1 jun 2024
Taseko Mines Limited (LSE: TKO) ("Taseko" or the "Company") announced today that operations at the Company's Gibraltar Mine have been suspended. Collective bargaining with Gibraltar's union representatives has been ongoing in recent weeks, and...

1 jun 2024
Takeda (TSE:4502/NYSE:TAK) and Pfizer today announced that the German Hodgkin Study Group (GHSG) will present positive results from the Phase 3 HD21 trial evaluating ADCETRIS® (brentuximab vedotin) in combination with chemotherapy as a late-breaking...



News published on and distributed by: